FDA approves Lilly's Foundayo (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions
The absence of effective therapies, coupled with the ongoing challenges of addressing underlying factors, is projected to increase the number of individuals affected by NAFLD in the U.S.A
uninsured patients often pay higher out-of-pocket rates, while those with compatible insurance may see reduced costs
doi:10.1016/0888-7543(91)90048-J
Copper toxicity typically occurs with chronic intake above 1015mg daily over months, presenting as gastrointestinal distress, hepatic dysfunction, or zinc depletion
prescriptions in its second week after launch, compared with 18,410 prescriptions for oral Wegovy in its second week after launch